NFKB1 and precursor B-cell acute lymphoblastic leukemia: Because PKC inhibition induced B-ALL sensitization to DEXA [16], VNC, and MTX (this study), through a decreased cell-adhesion-mediated mechanism, we evaluated drug sensitization in the presence of the BAY inhibitor of NF-κB.